HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
MONDAY, Jan. 22, 2018 (HealthDay News) -- In-office angiolytic laser procedures are effective for vocal fold polyps, though with occasional occurrence of minor adverse events, according to a study published online Jan. 18 in JAMA Otolaryngology-Head & Neck Surgery.
Yu-Hsuan Lin, M.D., from the National Cheng Kung University in Tainan, Taiwan, and colleagues examined the outcomes and incidence rates of adverse events associated with in-office angiolytic laser procedures with or without concurrent polypectomy in a retrospective cohort study. A total of 97 consecutive patients with vocal fold polyps who underwent in-office angiolytic laser treatments were enrolled; 29 patients had angiolytic laser procedures only and 68 received laser with concurrent polypectomy.
The researchers observed significant improvements for both treatment modalities. The need for multiple treatments was lower among patients receiving angiolytic laser with concurrent polypectomy versus those receiving laser treatment alone (1 versus 21 percent; effect size, −1.57; 95 percent confidence interval, −2.77 to −0.36). Eight adverse events were identified, including vocal fold edema, vocal hematoma, and vocal ulceration (five, two, and one events, respectively). Significantly fewer adverse events occurred among patients treated with laser plus concurrent polypectomy compared to those treated with angiolytic laser alone (3 versus 21 percent; effect size, 1.2; 95 percent confidence interval, 0.26 to 2.13).
"In-office angiolytic laser procedures can be an effective alternative treatment for vocal polyps, although with possible need for multiple treatment sessions and occasional occurrence of minor postoperative adverse events," the authors write.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 28, 2022